re: #213 Decatur Deb

Most uncomfortable with running groups who are CDC defined as high risk (which I read as multiply-high risk) in a very early placebo trial against a lethal agent.

I just don’t see the problem.

If the trial isn’t run then everybody gets the placebo.

If the trial is run without the placebo you can’t really tell if it works.

If the trial is run without at-risk people then you can’t really tell if it works.

The at-risk people on the trial are no worse off than if the trial wasn’t run.

You seem to be operating under the assumption that the vaccine works and so it’s somehow bad to be giving people the placebo if they could have the vaccine. But without the trial we won’t really know if the vaccine works.

And if you’re going to worry about the people in at-risk groups in the trial who are getting the placebo instead of the vaccine why not worry about the people in at-risk groups who are not on the trial and so certainly not getting the vaccine.